Latest Trials
Latest News
Products
FAQ
Pharmaceutical Companies
Pharma Details
AKITA UNIVERSITY HOSPITAL
🇯🇵
Japan
Country
🇯🇵
Japan
Ownership
-
Established
1971-01-01
Employees
-
Market Cap
-
Website
http://www.hos.akita-u.ac.jp/
Clinical Trials
Related News
Gemcitabine With Peptide Vaccine Therapy in Treating Patients With Bile Duct Cancer
Phase 1
Suspended
Conditions
Bile Duct Cancer
Interventions
Biological: Peptide vaccine for URLC10
Drug: Gemcitabine
Subscribe
First Posted Date
2008-02-26
Last Posted Date
2015-06-23
Lead Sponsor
Akita University Hospital
Target Recruit Count
9
Registration Number
NCT00624182
Locations
🇯🇵
Akita University Hosipital, Akita, Japan
Subscribe
Prev
1
Next
© Copyright 2025. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy